Total metabolic tumor volume for predicting cytokine release syndrome and treatment response in patients receiving bispecific antibodies for B-cell lymphoma. Efficacy and safety of polatuzumab vedotin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results